Results 121 to 130 of about 23,218 (270)

Persistent arterial wall inflammation in patients with elevated lipoprotein(a) despite strong low-density lipoprotein cholesterol reduction by proprotein convertase subtilisin/kexin type 9 antibody treatment [PDF]

, 2018
Lotte C.A. Stiekema, Erik S.G. Stroes, Simone L. Verweij, Helina Kassahun, Lisa Chen, Scott M. Wasserman, Marc S. Sabatine, Venkatesh Mani, Zahi A. Fayad   +8 more
openalex   +1 more source

Astragalus membranaceus—Salvia miltiorrhiza Decoction Ameliorates Metabolic Syndrome and Gut Microbiota Dysbiosis Induced by High‐Fat Diet: A Comparative Study

Food Science &Nutrition, Volume 14, Issue 1, January 2026.
The optimal pairing ratio of ASDs against hyperlipidemia was systematically investigated. ASD maintains intestinal homeostasis and improves the systemic inflammatory response. A new LC–MS/MS method for the determination of derivatized SCFAs was established. ASD regulates the gut microbiota and its metabolites (SCFAs and BAs).
Haiyin Zhang, Haofang Wan, Yihang Lu, Yu He, Haitong Wan, Chang Li   +5 more
wiley   +1 more source

Association of Remnant-like Particle Cholesterol with Major Adverse Cardiovascular Events in Subjects with Different Levels of Proprotein Convertase Subtilisin/Kexin 9: A 9.5-year Follow-up Study in a Beijing Community Population

, 2023
Xiaona Wang, Ruping Tie, Ruihua Cao, Xu Yang, Wenkai Xiao, Sheng Li, Ping Ye   +6 more
openalex   +1 more source

Proprotein convertase subtilisin/kexin type 9 in patients with systemic sclerosis.

Clinical and experimental rheumatology, 2020
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a serine protease that regulates cholesterol metabolism through low-density lipoprotein receptor degradation, and which has been linked to cardiovascular risk. The purpose of the present study was to examine whether PCSK9 serum levels are disrupted in patients with systemic sclerosis (SS ...
Ferraz Amaro, Iván, Delgado Frías, Esmeralda, Hernández Hernández, Vanessa, Sánchez Pérez, Hiurma, Armas Rillo, Laura de, García Dopico, José Antonio, Díaz González, Federico   +6 more
openaire   +2 more sources

Course of Pregnancy in a Woman With Familial Chylomicronemia Syndrome Treated With Plozasiran, a Small Interfering RNA Against ApoC3

JIMD Reports, Volume 67, Issue 1, January 2026.
ABSTRACT Persistent chylomicronemia is associated with severe hypertriglyceridemia (sHTG) and plasma triglycerides (TG) levels sustainably > 10 mmol/L (880 mg/dL) despite lipid lowering therapies. The main risk of persistent chylomicronemia is acute pancreatitis (AP). During the second and third trimester of pregnancy, TG levels significantly increase,
Miriam Larouche, Diane Brisson, Nathalie Roy, Claudy Grenon, Paul Poirier, Ma'an Muhsin, Daniel Gaudet   +6 more
wiley   +1 more source

Comment on: “Association of Fasting C-Peptide to High Density Lipoprotein Cholesterol Ratio with Non-Alcoholic Fatty Liver Disease in Chinese Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study” [Letter]

Diabetes, Metabolic Syndrome and Obesity
Kexin Hu,1,2 Hanwen Xu1 1Department of Endocrinology, The First People’s Hospital of Jiashan, Jiashan Hospital Affiliated to Jiaxing University, Jiaxing, Zhejiang, 314100, People’s Republic of China; 2Jiaxing Women and Children& ...
Hu K, Xu H
doaj  

Trans Embodiment, Aging, and the Heterotopia of Domestic Space: Reimagining Kinship and Futurity in For Nonna Anna and Wild Side

Forum
This article engages with the domestic space in two contemporary transgender narratives, For Nonna Anna (2017) and Wild Side (2004). Building on Michel Foucault’s concept of heterotopia, it argues that these films highlight the domestic sphere as a site ...
Kexin Zhang
doaj   +1 more source

Expression of LDLRs (Low-Density Lipoprotein Receptors), Dyslipidemia Severity, and Response to PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Inhibition in Homozygous Familial Hypercholesterolemia

, 2018
Raúl D. Santos
openalex   +1 more source

Lipid-lowering interventions targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): an emerging chapter in lipid-lowering therapy [PDF]

, 2017
Constantine E. Kosmas, Eddy DeJesus, Rosmery Morcelo, Frank Garcia, Peter D. Montan, Eliscer Guzman   +5 more
openalex   +1 more source

Isocoumarins and Benzoquinones with Their Proprotein Convertase Subtilisin/Kexin Type 9 Expression Inhibitory Activities from Dried Roots of Lysimachia vulgaris [PDF]

, 2022
Pisey Pel, Young‐Mi Kim, Hyun Ji Kim, Piseth Nhoek, Chae-Yeong An, Min-Gyung Son, Hongic Won, Seung Eun Lee, Jeong‐Hoon Lee, Hyun Woo Kim, Young Hee Choi, Chang Hoon Lee, Young‐Won Chin   +12 more
openalex   +1 more source